Now Offering
Spravato®
(esketamine)
What is Spravato® (esketamine)
Esketamine is an FDA-approved nasal spray developed for adults with treatment-resistant depression.
It is intended for patients who have tried multiple traditional antidepressant medications without adequate relief.
By working differently than standard options, esketamine offers a new pathway to hope and improved well-being for those who may have struggled with other treatments.
Key details about treatment:
Administered in-office as a nasal spray
Twice-weekly sessions for 6 weeks
Each visit includes a 2-hour observation period following administration
Clinical studies have shown significant improvement in mood and depressive symptoms in many patients